|
|
||||||||
Original Research |
From the Departments of Clinical Pharmacy (LBH)
Family Medicine (LBH, DF, RA-G, JMW, DW, WP), University of Colorado Health Sciences Center, Denver, CO
Correspondence: Corresponding author: Laura B. Hansen, PharmD, University of Colorado Health Sciences Center, School of Pharmacy, 4200 East 9th Avenue, Box C238, Denver, CO 80262 (E-mail: laura.hansen{at}uchsc.edu)
Introduction: Prescription errors threaten patient safety and pharmacists often contact providers for prescription clarification. This study describes the principal reasons pharmacies call primary care practices to clarify prescriptions and subsequent implications for quality and patient safety improvement.
Methods: A cross-sectional study of 22 primary care practices participating in a patient safety study was performed. Callbacks from pharmacies were logged for 2 weeks to determine reasons for callbacks, most frequently involved drug classes, whether issues were resolved on the same day of the call, and variability of callbacks among practice types. Analyses were performed using frequencies, t tests, and
2 tests.
Results: Practices recorded 567 clarification calls, most frequently for prior authorization issues (n = 209; 37%), formulary issues (n = 148; 26%), and unclear/missing prescription dosages (n = 117; 21%). Drug classes most frequently requiring clarifications were gastrointestinal (n = 122; 21.7%), cardiovascular (n = 278; 13.9%), and analgesic/anesthetic (n = 74; 13.2%) agents. Issues were resolved on the same day 62% of the time. Residency practices averaged more issues per call (P < .001).
Conclusions: Clarification calls made to primary care practices involve administrative and clinical issues, potentially impacting patient safety. Pharmacy callback data can identify potential prescription concerns, thereby helping practices develop interventions aimed at reducing errors and improving patient safety.
This article has been cited by other articles:
![]() |
G M Kuo, R L Phillips, D Graham, and J M Hickner Medication errors reported by US family physicians and their office staff Qual. Saf. Health Care, August 1, 2008; 17(4): 286 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. West, J. E. Wilk, I. L. Muszynski, D. S. Rae, M. Rubio-Stipec, C. L. Alter, W. E. Narrow, and D. A. Regier Medication Access and Continuity: The Experiences of Dual-Eligible Psychiatric Patients During the First 4 Months of the Medicare Prescription Drug Benefit Am J Psychiatry, May 1, 2007; 164(5): 789 - 796. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |